Scientists train Kids' own immune cells to hunt brain cancer
NCT ID NCT03334305
Summary
This early-stage study tested whether a personalized vaccine made from a child's own tumor could safely train their immune system to fight an aggressive brain cancer called high-grade glioma. The treatment involved two parts: a vaccine injected under the skin and a separate infusion of specially trained immune cells. The main goal was to check if this combined approach was safe and could trigger an immune attack against the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH GRADE GLIOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Children's National Hospital
Washington D.C., District of Columbia, 20010, United States
-
Children's of Alabama at UAB
Birmingham, Alabama, 35233, United States
-
UF Health Shands Children's Hospital
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.